Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Allergan, Inc v. Photomedex, Inc, et al
Case Number:
8:07-cv-01316
Court:
Nature of Suit:
Judge:
Firms
- Alston Hunt
- Ascension Law Group
- Conkle Kremer
- Dentons
- Dunlap Codding
- Finlayson Toffer
- Fish & Richardson
- Gallagher & Kennedy
- Gibson Dunn
- Graves & Shaw
- Hagens Berman
- Honigman LLP
- Jeffer Mangels
- Katten Muchin
- K&L Gates
- Knobbe Martens
- KXT Law
- Merchant & Gould
- Mintz Levin
- Morgan Lewis
- Perkins Coie
- Russ August & Kabat
- Sheppard Mullin
- Taft Stettinius
- Toberoff & Associates
- Towle Denison
- Venable LLP
- Warner Norcross
- Weiss & Moy
- Zuber Lawler
Companies
Sectors & Industries:
-
March 29, 2013
Allergan Drops Patent, Ad Claims Over Eyelash Drug Latisse
A California federal judge Thursday brought closer to an end Allergan Inc.'s long-running patent infringement and false advertising suit over its eyelash-enhancing drug Latisse after the company inked a deal that dropped competition and noninfringement claims by three rivals.
-
March 08, 2013
Judge Sides With Allergan On Eyelash-Growth Patent Claim
A California federal judge on Tuesday granted partial summary judgment to Allergan Inc. on its claim that Cosmetic Alchemy LLC induced its customers to infringe Allergan's patent on its popular eyelash growth drug Latisse, saying Allergan had proven its infringement allegations.
-
December 21, 2012
Allergan Rivals' Eyelash Treatments Are Drugs, Court Rules
A California federal judge on Thursday granted summary judgment to Allergan Inc. on unfair competition claims over the alleged marketing of copycat versions of its eyelash treatment Latisse, ruling the rival companies' products should be considered drugs.